DLD Asset Management »

Trevi Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $443k 35k 12.52
2025-09-30 $503k 55k 9.15

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Progress Software Corp Note 1.000% 4/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Advanced Energy Inds Note 2.500% 9/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Cidara Therapeutics Com New Call Option (CDTX)

View all positions for DLD Asset Management

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Vanguard Group
Vivo Capital
Marshall Wace
Alliancebernstein
Rubric Capital Management
FMR
MPM Oncology Impact Management
Wellington Management Company
Viking Global Investors
OrbiMed Advisors
Octagon Capital Advisors
Eventide Asset Management

View all funds holding Trevi Therapeutics